drugset / Trial / NCT00668135

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

NCT00668135

Phase 4 Completed 348 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate the efficacy, safety and tolerability of 10 mg oral vardenafil (BAY 38-9456) compared to placebo for a period of 12 weeks in men with erectile dysfunction (ED)

Timeline

Start
2003-03
Primary completion
2004-04
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 10 mg Oral

Indications